Bio-Works publishes half year report 2024
The first half in review Jan – Jun 2024 · Net sales decreased 41% to 13,0 MSEK (22,1) with. Sales in North America has been weak during the first half, while European sales have been somewhat stronger. We are looking forward to stronger sales in the second half, as a result of increased order intake. · Order intake increased by 16% to 18,3 MSEK (15,9). · Net profit for the first half was -18,9 MSEK (-28,8). The improvement can be explained by the cost reduction program, improved gross margins and lower OPEX. · Earnings per share in the first half of the year amounted to -0,